Clinical characteristics of primary and reactivated Epstein-Barr virus infection in children
- PMID: 32558948
- DOI: 10.1002/jmv.26202
Clinical characteristics of primary and reactivated Epstein-Barr virus infection in children
Abstract
Epstein-Barr virus (EBV) infection occurs commonly in children and presents as a primary or reactivated infection, which are difficult for clinicians to distinguish. This study investigated the clinical characteristics of the two types of infections. Children with detectable plasma EBV-DNA were retrospectively enrolled and divided into primary and reactivated infection group by EBV-specific antibody. We analyzed the patients' characteristics, clinical manifestations, complications, inflammatory biomarkers, and viral load. A total of 9.3% of children with reactivation were immunocompromised over the long-term. The primary infection mostly appeared as infectious mononucleosis (99.8%), while reactivation occurred as an infectious mononucleosis-like disease (65.0%), hemophagocytic syndrome (22.6%), chronic active EBV infection (5.3%) and lymphoma (3.5%). The incidence of fevers, cervical lymphoditis, periorbital edema, pharyngotonsillitis, hepatomegaly and splenomegaly in primary infection were 93.3%, 93.0%, 51.5%, 66.0%, 76.2% and 63.9%, respectively; the incidence of those symptoms in reactivation was 84.0%, 46.9%, 15.4%, 18.5%, 18.5%, and 43.3%, respectively. The incidence of digestive, respiratory, cardiovascular, neurological, hematological, genitourinary complications and multiple serous effusion in primary infection was 68.8%, 18.1%, 8.0%, 0.8%, 2.9%, 0.0% and 2.3%; whereas the incidence of these complications in reactivation was 56.2%, 22.5%, 14.1%, 8.0%, 38.9%, 0.3% and 19.0%. Patients with reactivation were more prone to multi-systemic damage. B-cells were lower, and CD8+ T-cells were higher in primary infection. Viral load was correlated with the level of different cytokines in primary and reactivated infection. EBV primary infection often presents as infectious mononucleosis. The reactivated infection affects more immunocompromised subjects with diverse and complex manifestations. Various complications are more commonly associated with reactivation as a result of different inflammatory responses to different types of infection.
Keywords: Epstein-Barr virus; inflammation; reactivation.
© 2020 Wiley Periodicals LLC.
Similar articles
-
Characteristics of primary Epstein-Barr virus infection disease spectrum and its reactivation in children, in Suzhou, China.J Med Virol. 2021 Aug;93(8):5048-5057. doi: 10.1002/jmv.26941. Epub 2021 Mar 25. J Med Virol. 2021. PMID: 33719067
-
Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.BMC Infect Dis. 2017 May 3;17(1):323. doi: 10.1186/s12879-017-2412-y. BMC Infect Dis. 2017. PMID: 28468603 Free PMC article.
-
Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.J Clin Virol. 2007 Apr;38(4):292-7. doi: 10.1016/j.jcv.2007.01.006. Epub 2007 Mar 1. J Clin Virol. 2007. PMID: 17336144
-
Atypical manifestations of Epstein-Barr virus in children: a diagnostic challenge.J Pediatr (Rio J). 2016 Mar-Apr;92(2):113-21. doi: 10.1016/j.jped.2015.06.007. Epub 2016 Jan 20. J Pediatr (Rio J). 2016. PMID: 26802473 Review.
-
Infectious mononucleosis and Epstein-Barr virus.Expert Rev Mol Med. 2004 Nov 5;6(23):1-16. doi: 10.1017/S1462399404008440. Expert Rev Mol Med. 2004. PMID: 15541197 Review.
Cited by
-
Repurposing of drug candidates against Epstein-Barr virus: Virtual screening, docking computations, molecular dynamics, and quantum mechanical study.PLoS One. 2024 Nov 15;19(11):e0312100. doi: 10.1371/journal.pone.0312100. eCollection 2024. PLoS One. 2024. PMID: 39546470 Free PMC article.
-
Cold Agglutinin Syndrome and Hemophagocytic Lymphohistiocytosis: An Unusual Combination Caused by Epstein-Barr Virus Infection.Cureus. 2024 Jan 12;16(1):e52179. doi: 10.7759/cureus.52179. eCollection 2024 Jan. Cureus. 2024. PMID: 38344610 Free PMC article.
-
Does COVID-19 cause an increase in spleen dimensions? Possible effects of immune activation, hematopoietic suppression and microthrombosis.Clin Imaging. 2021 Nov;79:104-109. doi: 10.1016/j.clinimag.2021.04.035. Epub 2021 Apr 28. Clin Imaging. 2021. PMID: 33932872 Free PMC article.
-
Role of 14-3-3 protein family in the pathobiology of EBV in immortalized B cells and Alzheimer's disease.Front Mol Biosci. 2024 Jul 31;11:1353828. doi: 10.3389/fmolb.2024.1353828. eCollection 2024. Front Mol Biosci. 2024. PMID: 39144488 Free PMC article.
-
Reactivation of Epstein-Barr virus in SFTSV infected patients.Infect Med (Beijing). 2023 May 12;2(3):195-201. doi: 10.1016/j.imj.2023.04.005. eCollection 2023 Sep. Infect Med (Beijing). 2023. PMID: 38073887 Free PMC article.
References
REFERENCES
-
- Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343(7):481-492.
-
- Coskun O, Yazici E, Sahiner F, et al. Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit. Med Klin Intensivmed Notfmed. 2017;112(3):239-245.
-
- Petrova M, Muhtarova M, Nikolova M, et al. Chronic Epstein-Barr virus-related hepatitis in immunocompetent patients. World J Gastroenterol. 2006;12(35):5711-5716.
-
- Ozcay F, Arslan H, Bilezikci B, Sevmis S, Moray G, Haberal M. The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients. Transplant Proc. 2009;41(7):2878-2880.
-
- Gulley ML, Tang W. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn. 2008;10(4):279-292.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials